To compare efficacy, safety and stability of Femtosecond assisted LASIK and implantable collamer lens implantation in correction of high myopia. METHODS: This study was non-randomized comparative prospective consecutive interventional study. It included 74 eyes with high myopia (≥ -6 Ds) of 40 patients attended to the outpatient ophthalmic clinic of Sohag university hospitals from the period from Jan.2016 to Jan.2017. The patients were divided into two groups depending on: Degree of myopia, corneal thickness and corneal tomography. The first group (34 eyes) of 20 patients were subjected to implantable collamer lenses implantation and the second group (40 eyes) of 40 patients were subjected to femtosecond assisted LASIK. RESULTS: Group one (ICL group) showed UCVA preoperative was (1.90±0.29) and UCVA postoperative was (0.27±0.21) with (p-value<0.000*). BCVA preoperative was (0.526±0.272) and that of BCVA postoperative was (0.217±0.128) with (p-value<0.001*), which means that BCVA postoperative was better than what was expected from the BCVA preoperative.
Introduction:
Myopia often known as "being short sighted" causes vision to be blurry in the distance but clearer when looking at things up close. Myopia eye which bends the coming light too much, which means that the light comes to a focus point before it reaches the retina. When moving closer to an object, this changes the focusing of the light and the object is then in focus on the retina and therefore looks clear. Myopia depends on:
• The length of the eyeball from front to back • How steep the cornea is • How powerful the lens is. Classification of myopia (1):
• Mild myopia includes powers up to -3.00 diopters (D)
• Moderate myopia, values of -3.00 to -6.00D • High myopia is usually myopia over -6.00D Phakic intraocular lenses (PIOLs) are generally accepted as an alternative treatment for ametropia correction among various refractive ranges. Fast visual recovery, high efficacy, predictability and stability of visual quality, preservation of accommodation, and reversibility are several advantages that have been attributed to PIOL implantation. (2, 3) The Visian Implantable Collamer Lens (ICL; STAAR Surgical Co, Monrovia, California) is approved by the United States Food and Drug Administration (FDA) for the treatment of moderate to severe myopia. The lens material, trade-named Collamer, is a hydrophilic collagen-polymer combination with a water content of 34% and a refractive index of 1.45. (2) ICL implantation can correct myopia (3, 4), hyperopia (5, 6), or astigmatism(7, 8), with clinical and visual results as good as or better than laser procedures (7, 8 Reducing the pulse duration reduces the amount of collateral tissue damage which makes FS laser safe to be used in corneal surgeries. (18, 19) Flap creation using (FS) , the suction ring is centered over the pupil and suction is applied once the proper centration of the ring has been ensured . The docking procedure is then initiated while keeping the suction ring parallel to the eye. An applanating glass contact lens is used to stabilize the globe and to flatten the cornea. It is important to achieve complete applanation of the cornea to avoid an incomplete flap or other flap related complications. Once the laser's computer has confirmed centration, the surgeon administers the FS laser treatment. Each pulse of the laser generates free electrons and ionized molecules leading to formation of microscopic gas bubbles dissipating into surrounding tissue. The tenets of the declaration of Helsinki were followed. Informed consent was obtained from each participant after verbal and written explanations of the nature and possible consequences of the study were provided .The study protocol received institutional review board approval.
INTRAOCULAR LENS
The Visian ICL is a plate-haptic single-piece intraocular lens, which is a flexible. It can be folded and implanted in the posterior chamber via a 2.8-3.2 mm corneal incision. It has a high degree of biocompatibility, good permeability of gases and metabolites, and good absorption of ultraviolet radiation. The ICL design has been modified many times in the past. In this study, the phakic IOL patients were ICL V4c lens designs. The ICL V4c is a 6.00 mm wide lens and comes in four sizes (12.1, 12.6, 13.2 and 13.7 mm in length). Its optic zone diameter is 4.9-5.8 mm, with a spherical power range of -0.50 to -18.00 DS and a cylindrical power range of +0.50 to +6.00 DC. ICL power calculations were performed by the manufacturer (STAAR Surgical) using a modified vertex formula. The variables in the formula included preoperative manifest spherical and cycloplegic refractions, keratometric power, central corneal thickness and central ACD (ACD, Pentacam, measured from the corneal endothelium to the anterior lens). The size (length) of the implanted ICL was determined based on the patient's WTW and ACD. For the ICL V4c, the sizes (lengths) of 12.1, 12.6, 13.2 and 13.7 mm were equal to the ICL V4 sizes (lengths) of 11.5, 12.0, 12.5 and 13.0 mm, respectively. (23 Both groups showed high efficacy, but Group1 showed more safety. Group1 showed 100% stability while group2 showed 71.4%, as shown in the below graph.
Graph showing difference in stability between both groups
DISCUSSION
The aim of this study was to evaluate the visual outcomes of femtosecond LASIK in comparison with implantable collamer lenses for correction of high myopia regarding visual acuity, high order aberrations, contrast sensitivity, efficacy, safety and stability. The patients were divided into two groups .The first group was subjected to implantable collamer lenses implantation and the second group subjected to femtosecond assisted LASIK. Excimer laser surgeries proved effectiveness for myopia correction, but they have complications such as myopic regression and ectasia which were reported in eyes with high myopia (29, 30) .Correction of high myopia is associated with increased HOAs (31) . It is proved that Phakic IOL implantation has predictability in correction of high myopia (32, 33) .Implantation of PIOL can induce complications such as cataract, lens dislocation and elevation of intraocular pressure. Therefore ,assessing visual and outcomes of PIOL is helpful when selecting the more appropriate , safe ,stable and effective procedure to 
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Group 1 correct high myopia ,especially when the patients have an overlapping range of both procedures (34) . Our study showed excellent refractive and visual outcomes with both ICL implantation and Femtosecond assisted LASIK.
The study showed that with a pupillary diameter 3-mm, VA values are improved in 100% of cases which can be up to (0.1 logMAR or more) after 6 months follow up (p<0.000*). There is agreement between our results and results of Paul and Taylor who studied refractive outcomes and safety of the implantable collamer lens in young low to moderate myopes. Their study was retrospective study performed by chart review of (104 eyes) with 50 months follow up period (35) . The results of group two (Femtosecond assisted LASIK group)from the visual quality point of view with a pupillary diameter 4-mm,VA values improved in 100% of cases which is up to (0 .1 logMAR or more ) after 6 months follow up, evaluated (p<0.00*).This result is consistent with that of Cari Perez-Vives et al (36) .Contrast sensitivity in photopic conditions increased comparing preoperative BCVA and postoperative BCVA with (p<0.007* ).This result is consistent with Cari Perez -Vives et al. and JOO youn SHIN, et al (34, 36) . Both groups showed high efficacy and safety, but group one (ICL) showed more stability during the follow up period than group two (Femtosecond Lasik). These finding were consistent with that of Xun Chen et, al. who studied contralateral eye comparison of the long-term visual quality and stability between implantable collamer lens and laser refractive surgery for myopia. Their study conducted on 52 eyes of 26 high-myopia anisometropia patients who were suitable for surgical treatment. In each patient, the higher-myopia eye was implanted with ICL and the lower-myopia eye was treated with LRS. The patients were followed for 3 years (37 
